CND, Beth Israel team on diagnostic tests for neurodegenerative diseases
CND Life Sciences has signed a licensing and collaboration agreement with Beth Israel Deaconess Medical Center (BIDMC) in Boston to develop minimally invasive, diagnostic tests for Parkinson’s and other neurodegenerative diseases. The agreement will give CND access to technology linked to its Syn-One Test, a diagnostic skin…